Where does Noven Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Noven Pharmaceuticals, Inc. ranks #10,413 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Noven Pharmaceuticals, Inc. hold?

Noven Pharmaceuticals, Inc. holds 30 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Noven Pharmaceuticals, Inc.'s Innovation Score?

Noven Pharmaceuticals, Inc. has an Innovation Score of 42.7 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Noven Pharmaceuticals, Inc. focus on?

Noven Pharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 29 patents, ranking #787 of 7,163 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Noven Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Noven Pharmaceuticals, Inc.'s recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Noven Pharmaceuticals, Inc.'s patents?

Noven Pharmaceuticals, Inc.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Noven Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Noven Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 30 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Noven ranks #10,413 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 12 technology areas.

#10,413
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.7/100): 19.8
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10413 · US Corporation #10,413 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,413/49,997
PHOTO-FINISH Mitsubishi Power…
CPC-FOCUS A61K · 12 areas
INNOV-PAR 42.7/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mitsubishi Power Americas, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Noven’s 42.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (28%) Velocity 6.7 pts (16%) Breadth 12.2 pts (29%) Claim depth 11.9 pts (28%)

Qualcomm Incorporated · highest

85
8×8 · near

43
Bionano Genomics · near

43
Noven Pharmaceuticals · this assignee

43
Qwtip · near

43
Wireless Advanced… · near

43
3D Lighting… · lowest

7

What this shows Noven's Innovation Score is 42.7/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Noven?

Each dot is one of Noven’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Noven’s own 19.8 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Noven vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Noven's grants concentrate

Noven Pharmaceuticals, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 96.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2024. By volume, Noven sits between Mitsubishi Power Americas, Inc. and No Longer Naked Lures, LLC.

Noven's three-year grant acceleration

Noven Pharmaceuticals, Inc. shows 6 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mitsubishi Power…

30
Mythic

30
National Institut…

30
Nippon Closures

30
Nucletron Operati…

30
Neumodx Molecular

30
Nevis Industries

30
No Longer Naked L…

30
Noven Pharmaceuti… ◀

30

What this shows Noven holds 30 patents at rank #10,408, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Noven

By rank, the assignees closest to #10,408 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Noven's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Noven, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Noven ranks #787 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Qwtip LLC 43 Bionano Genomics, Inc. 43 Wireless Advanced Vehicle Electrification, LLC 43 8×8, Inc. 43

Noven's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Noven Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.7%
2016	6	20.0%
2017	5	16.7%
2018	3	10.0%
2019	4	13.3%
2021	2	6.7%
2022	3	10.0%
2023	2	6.7%
2024	1	3.3%
2025partial year	2	6.7%

Which technologies does Noven Pharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 29

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07C - Acyclic OR Carbocyclic Compounds 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 2

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Noven Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Noven Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #10,413 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Noven Pharmaceuticals, Inc. against Mitsubishi Power Americas, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.